Daily Archives: February 23, 2022 | LinksMedicus Free Medical News & Perspectives

USPSTF Draft Statement: Statin use for the primary prevention of cardiovascular disease in adults.

23 Feb, 2022 | 10:45h | UTC

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication – U.S. Preventive Services Task Force

Commentary: USPSTF Updates Guidance on Statins for Primary Prevention of CVD – HealthDay

WHO/UNICEF: More than half of parents and pregnant women exposed to aggressive formula milk marketing.

23 Feb, 2022 | 10:42h | UTC

More than half of parents and pregnant women exposed to aggressive formula milk marketing – WHO, UNICEF – World Health Organization

Commentary: Aggressive’ marketing of formula milk flouts code, warns WHO as it urges curbs – The Guardian

Commentary on Twitter

"We have been targeted with marketing from formula milk companies."

Over half of parents & pregnant women exposed to formula milk marketing, violating international standards and harming child health
-? WHO, @UNICEF survey

➡️ https://t.co/86Bf69PSeK #EndExploitativeMarketing pic.twitter.com/BuhQPgM3OX

— World Health Organization (WHO) (@WHO) February 22, 2022

AHA Scientific Statement: Strategies to reduce low-value cardiovascular care.

23 Feb, 2022 | 10:43h | UTC

Strategies to Reduce Low-Value Cardiovascular Care: A Scientific Statement From the American Heart Association – American Heart Association

News Release: Do you really need that test? New statement highlights need to reduce “low-value” heart care – American Heart Association

WHO: Here are the 16 ‘best buys’ to tackle non-communicable diseases.

23 Feb, 2022 | 10:19h | UTC

WHO: Here Are The 16 ‘Best Buys’ To Tackle Non-Communicable Diseases – Forbes

Original Report: WHO Report | Saving lives, spending less: the case for investing in noncommunicable diseases.

RCT: Sublingual dexmedetomidine reduces mild to moderate acute agitation in patients with bipolar disorder.

23 Feb, 2022 | 10:18h | UTC

Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Sublingual Dexmedetomidine as a Potential New Treatment for Agitation – JAMA (free for a limited period)

Commentary on Twitter

Randomized clinical trial found sublingual #dexmedetomidine at a dose of 180 μg or 120 μg reduced mild to moderate agitation in patients with #bipolar disorder. https://t.co/1VK2e15F7s pic.twitter.com/0oHw6eVMIP

— JAMA (@JAMA_current) February 22, 2022

AGA Guideline on systemic therapy for hepatocellular carcinoma.

23 Feb, 2022 | 10:14h | UTC

AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma – Gastroenterology

News Release: AGA recommends shared decision-making approach for treatment of hepatocellular carcinoma – American Gastroenterology Association

Consensus Paper: Clinical applications of cardiac computed tomography.

23 Feb, 2022 | 10:12h | UTC

Part I: Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging – European Heart Journal – Cardiovascular Imaging

Part II: Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging – European Heart Journal – Cardiovascular Imaging

Large registry-based study in the U.S. suggests infertility treatments are associated with increased risks for pregnancy and vascular complications.

23 Feb, 2022 | 10:16h | UTC

In‐Hospital Complications in Pregnancies Conceived by Assisted Reproductive Technology – Journal of the American Heart Association

News Release: Common infertility treatments may increase risks for pregnancy, vascular complications – American Heart Association

Commentary: Infertility treatments raise risk of heart and pregnancy complications, study finds – CNN

Consensus Paper: Non-invasive imaging in coronary syndromes.

23 Feb, 2022 | 10:10h | UTC

Non-invasive imaging in coronary syndromes: recommendations of the European Association of Cardiovascular Imaging and the American Society of Echocardiography, in collaboration with the American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance – European Heart Journal – Cardiovascular Imaging

ASCO Guideline Update: Adjuvant systemic therapy and adjuvant radiation therapy for stage I-IIIA completely resected non–small-cell lung cancer.

23 Feb, 2022 | 10:08h | UTC

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I-IIIA Completely Resected Non–Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update – Journal of Clinical Oncology

Commentary: Rapid Guideline Revises Recommendations for Adjuvant Therapy in Patients With Early-Stage Lung Cancer – ASCO Daily News

Commentary on Twitter

‼️ Just published in #JCO: @ASCO rapid guideline update on adjuvant systemic therapy & adjuvant radiation therapy for stage I to IIIA completely resected #NSCLC ? https://t.co/OheQi7Bi97 #lcsm #radonc pic.twitter.com/Dax2orUXZy

— Journal of Clinical Oncology (@JCO_ASCO) February 15, 2022